About JBRHA

1. Aims & Scope

Journal of Biological Regulators and Homeostatic Agents (JBRHA, Print ISSN: 0393-974X, Electronic ISSN: 1724-6083) is a peer-reviewed journal published 12 issues per year. The journal is committed to publishing the full range of topics in the fields of experimental and clinical medicine, molecular biology, biochemistry, regulatory molecules, cellular immunology and pharmacology and the single most important criterion for acceptance is scientific excellence. The content of the article includes putting forward and verifying some hypotheses, new ideas or new problems to be solved, as well as novel findings from experiment, which will provide new perspectives and methods for understanding these topics, and stimulate the interest of the journal readers.


2. Impact Factor

Publication Frequency: 12 issues per year.
Current Impact Factor: 2.843
JCR Category: 1. ENDOCRINOLOGY & METABOLISM; 2. IMMUNOLOGY; 3. MEDICINE, RESEARCH & EXPERIMENTAL; 4. PHYSIOLOGY


3. JBRHA'S Open Access Initiative

The advent of online publication has greatly improved access to scientific content on a global scale. This has led to calls from the academic community for research publications to be made freely available online and immediately upon publication, without the barrier of paid subscription to access.

In response to these calls, and following consultation with journal contributors, the Editors of JBRHA launched an Open Access initiative for JBRHA in 1 June 2022. This means that manuscripts which submitted from 1 June 2022 and accepted after peer review will be published in JBRHA with open access under the CC BY license.

There are substantial costs associated with publishing a high quality journal such as JBRHA, including administration of the editorial process, production of the published version, and development of online functionality. Under a subscription-based model, these costs are mainly covered by charging libraries and individuals for access to the journal's contents. Under JBRHA's Open Access model, we aim to cover the costs of publication primarily through the use of an Article Processing Charge. For details, see: Article Processing Charge.


4. Copyright/Open Access

(1) Published under the subscription model and open access options

Most of papers published in Volume 20 Issue 1 – Volume36 Issue 2(S2) (from 2006 to 31 May 2022) are copyright JBRHA, and the author(s) retains copyright to individual articles. Manuscripts which submitted before 1 June 2022 and accepted after peer review will be published in JBRHA and also are copyright JBRHA.

In most instances, JBRHA may make its content freely viewable and searchable. JBRHA grants any third party the right to use most articles freely, as long as its integrity is maintained and its original author, citation details and journal are identified. However, some articles may require permission to be re-used, as determined on a case-by-case basis. To seek permission, please see the information: Permissions Request.

(2) Published under an Open Access Creative Commons licence

Manuscripts which submitted from 1 June 2022 and accepted after peer review will be published in JBRHA with open access under the CC BY 4.0 license. JBRHA is not authorized to grant permission for material published under CC BY license, as the authors retain copyright. However, depending on the intended use, permission may not be required at all. For details, see: Copyright & License.

JBRHA will insert the following note on the first page of the published text:
© Year The Author(s). Published by Biolife Sas. This is an open access article under the CC BY 4.0 license.


5. Journal History

1987      JBRHA released the inaugural issue.
1987      JBRHA has been indexed by Scopus.
1995      JBRHA has been indexed by SCIE.
1997      JBRHA received its first Impact Factor 0.455.
2021      JBRHA received its latest Impact Factor 2.843.
2022      Manuscripts which submitted from 1 June 2022 and accepted after peer review will be published in JBRHA with open access under the Creative Commons Attribution (CC BY ) license.